The Scientist

» FDA and disease/medicine

Most Recent

image: Smallpox Kerfuffle Reveals Biosecurity Problems

Smallpox Kerfuffle Reveals Biosecurity Problems

By | July 12, 2017

A review of a 2014 incident in which mystery vials of smallpox were found at the NIH reveals security weaknesses, but also concludes the response was appropriate. 

1 Comment

image: Anti-Preeclampsia Hormone Discovered

Anti-Preeclampsia Hormone Discovered

By | June 29, 2017

A small, placenta-produced peptide fixes the pregnancy-related condition in mice. 

1 Comment

image: Art’s Diagnosticians

Art’s Diagnosticians

By | June 12, 2017

Physicians peer into the subjects of artistic masterpieces, and find new perspective on their own approach to diagnosing maladies.

0 Comments

The new findings, obtained from cell culture experiments, could explain the link between infection with the virus during pregnancy and infant microcephaly.

1 Comment

image: Micronutrients, Macro Impact

Micronutrients, Macro Impact

By | June 1, 2017

At the interface of food, nutrition, and agriculture, Lindsay Allen’s research has been informing nutrition guidelines and policies around the world for decades.

1 Comment

image: Pinpointing the Culprit

Pinpointing the Culprit

By | June 1, 2017

Identifying immune cell subsets with CyTOF

0 Comments

image: The Celiac Surge

The Celiac Surge

By | June 1, 2017

A rapid increase in the global incidence of the condition has researchers scrambling to understand the causes of the trend, and cope with the consequences.

4 Comments

image: Opinion: Token Pharmacovigilance

Opinion: Token Pharmacovigilance

By | May 23, 2017

A US government website for collecting reports of side effects associated with vaccines is broken. Why has no one noticed?

4 Comments

Four products have already qualified for the regenerative medicine advanced therapy (RMAT) designation that provides extra interactions with the agency, and sooner.

0 Comments

image: Second-Ever ALS Drug Approved

Second-Ever ALS Drug Approved

By | May 8, 2017

Amyotrophic lateral sclerosis patients in the U.S. now have an option besides riluzole, which was approved by the FDA more than two decades ago and only extends life by two or three months.

1 Comment

Popular Now

  1. A Potential Remedy for the Aging Brain
    The Scientist A Potential Remedy for the Aging Brain

    In mice, injected fragments of a naturally occurring protein boost memory in young and old animals and improve cognition and mobility in a model of neurodegenerative disease. 

  2. The Sleeping Brain Can Learn
    Daily News The Sleeping Brain Can Learn

    Humans can remember new sensory information presented during REM sleep, but this ability is suppressed during deep, slow-wave slumber.

  3. USDA Emails: Don’t Use “Climate Change”
  4. Nature Index Identifies Top Contributors to Innovation
AAAS